Coagadex Kit
Product Images NDC 64208-7752
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Coagadex (NDC 64208-7752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bio Products Laboratory Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Step 3 (Coagadex 02)
Step 4 (Coagadex 03)
Step 5 (Coagadex 04)
Step 6 And 7 (Coagadex 05)
Step 8 (Coagadex 06)
Step 1 And 2 (Coagadex 07)
Step 3 (Coagadex 08)
Step 4 (Coagadex 09)
Step 5 (Coagadex 10)
Step 6 And 7 (Coagadex 11)
Step 8 (Coagadex 12)
Principal Display Panel (250 IU Kit Carton)
This is a description of the medication Coagadex, which includes storage instructions, dosage and administration, and a list of inactive ingredients. Coagadex is a lyophilized powder for solution for injection containing 250 IU range of coagulation Factor X, which should be used within one hour of reconstitution/dissolving. The product does not contain preservatives, is not made with natural rubber latex, and should be stored between 36°F and 86°F (2°C - 30°C) but should not be frozen. The vial should be kept in the outer carton to protect from light. A package insert and a transfer device are included with the product. Coagadex is manufactured by Bio Products Laboratory Limited and is a registered trademark in the United States.*
Principal Display Panel (500 IU Kit Carton)
This is a description of a medication named Coagulation FactorX used for intravenous purposes only. The distributor of this medication is Bio Products Laboratory USA Inc. which is located in Durham, North Carolina, USA. Additionally, the product is identified as a human protein and has a unique serial number of US License No. 1811.*
Coagadex 15
Coagadex 16
Coagadex is a medication used for intravenous use only and contains coagulation factor X for patients with hereditary Factor X deficiency. The medication comes as a lyophilized powder for solution for injection and should be stored between 36°F - 86°F. The vial should be kept within the outer carton to protect it from light and should not be frozen. The medication comes with a package insert that contains information about dosage and administration, and the product contains no preservatives or natural rubber latex. Upon reconstitution with sterile water for injection, Coagadex contains approximately 100 1U/mL coagulation Factor X and inactive ingredients. It is produced by Bo Products Laboratory Limited and is a registered trademark in the U.S.*
Coagadex 17
Coagadex is a coagulation Factor X medication for intravenous use, manufactured by Bio Products Laboratory Ltd in the United Kingdom. The package contains 3 pockets and is available in the USA. It is important not to prepare or take this medication without proper guidance. However, the remaining text is not available due to errors.*
Coagadex 18
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.